Ticker
ENTACompany Name
ENANTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow to Operating Cash Flow | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ -43.57M | 0% | $ -23.18M |
3/31/2025 | $ -82.24M | 0% | $ -55.46M |
12/31/2024 | $ -96.48M | 0% | $ -70.58M |
9/30/2024 | $ -96.71M | 0% | $ -78.76M |
6/30/2024 | $ -100.33M | 0% | $ -89.97M |
3/31/2024 | $ -113.29M | 0% | $ -107.32M |
12/31/2023 | $ -99.19M | 0% | $ -92.5M |
9/30/2023 | $ -112.21M | 0% | $ -103.15M |
6/30/2023 | $ -106.21M | 0% | $ -97.09M |
3/31/2023 | $ -101.79M | 0% | $ -94.56M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / CF - Operations
(=) FCF/OCF
FCF/OCF for ENANTA PHARMACEUTICALS INC is calculated as follows: FCF [ $ 5.64M ] / CF - Operations [ $ 7.09M ]
(=) FCF/OCF [ 79.61% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 2.51K |
---|---|
min | -23% |
max | 171.58% |
average | 71.45% |
median | 80.76% |
std | 29.09% |